financetom
Personal Finance
financetom
/
Personal Finance
/
Research Alert: CFRA Raises Opinion On Shares Of Arista Networks, Inc. To Buy From Hold
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Research Alert: CFRA Raises Opinion On Shares Of Arista Networks, Inc. To Buy From Hold
May 9, 2024 11:43 AM

02:25 PM EDT, 05/09/2024 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows:

We raise our 12-month target price by $50 to $350, 44.4x our '24 EPS estimate, a premium to its five-year historical average P/E at 36.8x, reflecting our stronger growth outlook and recent results. We increase our '24 EPS estimate by $0.41 to $7.88 and raise '25's by $0.43 to $8.90. ANET reported Q1 operating EPS of $1.99 vs. $1.43, $0.25 above the consensus. Q1 revenue increased 16.3%, driven by strong growth in the U.S. with solid contributions from its Cloud Titan and Enterprise customers. ANET raised its full-year revenue growth guidance to 12%-14% from 10%-12%, but we believe this guidance is still conservative given the positive underlying trends for the company. We are becoming increasingly positive on the impact of AI demand for ANET, as the company expects revenue contributions later this year, with the total jumping to $750 million in '25. We believe this is a strong long-term opportunity for ANET, with $750 million being just the tip of the iceberg.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Research Alert: CFRA Raises Opinion On Adss Of Gsk To Buy From Hold
Research Alert: CFRA Raises Opinion On Adss Of Gsk To Buy From Hold
Oct 30, 2025
06:20 AM EDT, 10/30/2025 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We raise our opinion on GSK to Buy from Hold and revise our target price to USD53 from USD40 following strong Q3 results and a guidance upgrade, which sits at...
Research Alert: CFRA Maintains Buy Opinion On Shares Of Meta Platforms
Research Alert: CFRA Maintains Buy Opinion On Shares Of Meta Platforms
Oct 30, 2025
08:25 AM EDT, 10/30/2025 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We cut our 12-month target to $804 from $880, on lower P/E of 24x our '27 EPS view, within historical. After better-than-expected Q3 sales/EPS (ex. one-time tax charge), we up...
Research Alert: CFRA Keeps Hold Opinion On Shares Of Lincoln National Corporation
Research Alert: CFRA Keeps Hold Opinion On Shares Of Lincoln National Corporation
Oct 30, 2025
09:45 AM EDT, 10/30/2025 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: LNC posted Q3 operating EPS of $2.04 vs. $2.06, topping our $1.80 EPS estimate and the $1.87 consensus view. Operating revenues rose 10.8% vs. our 3%-6% growth forecast, driven by...
Research Alert: CFRA Maintains Strong Buy Opinion On Shares Of Microsoft Corporation
Research Alert: CFRA Maintains Strong Buy Opinion On Shares Of Microsoft Corporation
Oct 30, 2025
07:05 AM EDT, 10/30/2025 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We keep our 12-month target price at $620, on a P/E of 31.1x our CY 27 view of $19.93, near its five-year historical forward average. After posting better-than-expected Sep-Q results,...
Copyright 2023-2025 - www.financetom.com All Rights Reserved